ARCUS BIOSCIENCES INC (RCUS)

US03969F1093 - Common Stock

15.5  +0.04 (+0.26%)

After market: 15.09 -0.41 (-2.65%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
382.9M
394.06%
112M
-70.75%
117M
4.46%
265.74M
127.13%
216.9M
-18.38%
233.57M
7.69%
285.73M
22.33%
650.76M
127.75%
959.86M
47.50%
1.328B
38.35%
1.385B
4.29%
EBITDA
YoY % growth
58M
147.89%
-274M
-572.41%
-332M
-21.17%
-300.79M
9.40%
-297.541M
1.08%
-462.762M
-55.53%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
54.2M
143.64%
-280M
-616.61%
-340M
-21.43%
-341.713M
-0.50%
-429.816M
-25.78%
-468.504M
-9.00%
-487.035M
-3.96%
-128.061M
73.71%
185.24M
244.65%
505.21M
172.73%
716.74M
41.87%
Operating Margin
14.16%-250.00%-290.60%-128.59%-198.16%-200.58%-170.45%-19.68%19.30%38.04%51.75%
EPS
YoY % growth
0.43
118.30%
-3.72
-965.12%
-4.15
-11.56%
-3.45
16.92%
-4.90
-42.07%
-4.48
8.55%
-4.71
-5.05%
-2.22
52.75%
-1.27
42.81%
1.32
204.01%
4.11
210.40%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27
EPS
Q2Q % growth
-1.26
-16.47%
-1.22
-2,337.80%
-1.26
-23.75%
-1.29
-28.77%
-1.35
-7.58%
-1.32
-8.54%
-1.29
-2.14%
-1.32
-2.34%
-1.34
1.18%
-1.37
-3.86%
-1.27
1.42%
-1.15
12.62%
Revenue
Q2Q % growth
29.478M
-4.91%
43.35M
-70.10%
40.8M
4.62%
40.8M
-15.00%
39.1M
32.64%
25.5M
-41.18%
25.5M
-37.50%
25.5M
-37.50%
25.5M
-34.78%
26.73M
4.82%
36.141M
41.73%
53.019M
107.92%
EBITDA
Q2Q % growth
-112.948M
-36.08%
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-124.426M
-36.73%
-106.42M
-2,760.50%
-113.22M
-6.81%
-117.98M
-12.36%
-114.75M
7.78%
N/AN/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-1.00
-6.38%
-1.080.087.78%
Q2 2024
Q2Q % growth
-1.02
1.92%
-1.120.108.92%
Q1 2024
Q2Q % growth
-0.05
95.41%
-0.970.9294.85%
Q4 2023
Q2Q % growth
-1.08
-16.13%
-1.04-0.04-3.39%
Q3 2023
Q2Q % growth
-0.94
-4.44%
-1.150.2118.35%
Q2 2023
Q2Q % growth
-1.04
-11.83%
-1.120.087.19%
Q1 2023
Q2Q % growth
-1.09
-13.54%
-1.190.108.14%
Q4 2022
Q2Q % growth
-0.93
-125.07%
-1.090.1614.53%
Q3 2022
Q2Q % growth
-0.90
18.92%
-1.060.1614.99%
Q2 2022
Q2Q % growth
-0.93
14.68%
-0.960.033.18%
Q1 2022
Q2Q % growth
-0.96
11.11%
-0.88-0.08-9.30%
Q4 2021
Q2Q % growth
3.71
552.44%
-0.764.47589.04%
Q3 2021
Q2Q % growth
-1.11
-3,800.00%
-1.10-0.01-1.15%
Q2 2021
Q2Q % growth
-1.09
-17.20%
-0.89-0.20-22.28%
Q1 2021
Q2Q % growth
-1.08
-71.43%
-0.84-0.24-27.86%
Q4 2020
Q2Q % growth
-0.82
-115.79%
-0.76-0.06-7.29%
Q3 2020
Q2Q % growth
0.03
105.88%
0.05-0.02-41.18%
Q2 2020
Q2Q % growth
-0.93
-45.31%
-0.62-0.31-49.04%
Q1 2020
Q2Q % growth
-0.63
-53.66%
-0.58-0.05-9.44%
Q4 2019
Q2Q % growth
-0.38
-35.71%
-0.520.1426.77%
Q3 2019
Q2Q % growth
-0.51
-104.00%
-0.50-0.01-2.92%
Q2 2019
Q2Q % growth
-0.64
-100.00%
-0.41-0.23-55.31%
Q1 2019
Q2Q % growth
-0.41
70.07%
-0.36-0.05-14.60%
Q4 2018
Q2Q % growth
-0.28 -0.450.1737.82%
Q3 2018
Q2Q % growth
-0.25 -0.380.1334.94%
Q2 2018
Q2Q % growth
-0.32 -0.400.0820.84%
Q1 2018
Q2Q % growth
-1.37 -0.90-0.47-51.82%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
48M
50.00%
38.307M9.693M25.30%
Q2 2024
Q2Q % growth
39M
34.48%
26.125M12.875M49.28%
Q1 2024
Q2Q % growth
145M
480.00%
34.54M110.46M319.80%
Q4 2023
Q2Q % growth
31M
-8.01%
28.935M2.065M7.14%
Q3 2023
Q2Q % growth
32M
-4.76%
27.828M4.172M14.99%
Q2 2023
Q2Q % growth
29M
8.21%
30.904M-1.904M-6.16%
Q1 2023
Q2Q % growth
25M
38.89%
25.467M-467K-1.83%
Q4 2022
Q2Q % growth
33.7M
-90.49%
23.773M9.927M41.76%
Q3 2022
Q2Q % growth
33.6M
253.68%
22.325M11.275M50.50%
Q2 2022
Q2Q % growth
26.8M
182.11%
21.548M5.252M24.37%
Q1 2022
Q2Q % growth
18M
89.47%
27.158M-9.158M-33.72%
Q4 2021
Q2Q % growth
354.5M
3,631.58%
40.175M314.325M782.39%
Q3 2021
Q2Q % growth
9.5M
-85.27%
9.588M-88K-0.92%
Q2 2021
Q2Q % growth
9.5M
427.78%
13.316M-3.816M-28.66%
Q1 2021
Q2Q % growth
9.5M
427.78%
12.49M-2.99M-23.94%
Q4 2020
Q2Q % growth
9.5M
-3.06%
8.087M1.413M17.47%
Q3 2020
Q2Q % growth
64.5M
3,483.33%
49.113M15.387M31.33%
Q2 2020
Q2Q % growth
1.8M 1.664M136K8.17%
Q1 2020
Q2Q % growth
1.8M 1.562M238K15.24%
Q4 2019
Q2Q % growth
9.8M
512.50%
1.588M8.212M517.13%
Q3 2019
Q2Q % growth
1.8M
-58.14%
1.567M233K14.87%
Q2 2019
Q2Q % growth
1.8M
38.46%
3.413M-1.613M-47.26%
Q1 2019
Q2Q % growth
1.8M
38.46%
1.649M151K9.16%
Q4 2018
Q2Q % growth
1.6M 969K631K65.12%
Q3 2018
Q2Q % growth
4.3M 2.601M1.699M65.32%
Q2 2018
Q2Q % growth
1.3M 1.301M-1K-0.08%
Q1 2018
Q2Q % growth
1.3M 1.301M-1K-0.08%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-3.98% -6.79% -1.95% -10.81%
Revenue-3.23% 18.62% 6.65% -2.44%